Selection of kavalactones by complexation of kava extract with cyclodextrins

Drug Development and Industrial Pharmacy

Volumn 23, Issue 12, 1997, Pages 1223-1226

  Amdidouche Hussain, Didja ^a   Levesque, Joël ^a  

^a Faculte de Medicine et de Pharmacie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CYCLODEXTRIN; GAMMA CYCLODEXTRIN; KAVA EXTRACT; KAVALACTONE; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; DRUG FORMULATION; DRUG SOLUBILITY; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0031472526     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049709146161     Document Type: Article

References (14)

1. H. J. Meyer, Pharmacology of kava, in Ethnopharmacologic Search for Psychoactives drugs (D. H. Efron, B. Holmstedt, and N. S. Kline eds.), Raven Press, New York, 1979.
2. V. Lebot, M. Merlin, and L. Lindstrom, Kava the Pacific Drug. Yale University Press, New Haven, 1992.
3. R. M. Smith, Kavalactones in Piper methysticum From Fiji, Phytochem., 22, 1055-1056 (1983).
4. Y. N. Singh, Kava an overview, J. Ethnopharmacol., 37, 13-45 (1992).
5. D. D. Jamieson and P. H. Duffield, The antinociceptive actions of Kava components in mice, Clin. Exp. Pharmacol. Phys., 17, 495-508 (1990).
6. V. Pornet. Développement d'une microémulsion à base de kavalactones, essais pharmacodynamiques. Thèse de Doctorat de l'Université de Poitiers, France, 1991.
7. V. Lebot, Les Kavas en océanic (Piper methysticum Forst. et Piper Wichmannii C. DC.), Thèse de Doctorat es Sciences, Université des Sciences et Techniques du Languedoc, France, 1988.
8. D. Duchěne, B. Debruère, and A. Brétillon, Les cyclodextrines: nature, origine et intérêt en Pharmacie Galénique, Labo Pharma Prob. Tech. 32, 842-850 (1984).
9. D. Amdidouche, D. Darrouzet, D. Duchène, and M-C Poelman, Inclusion of retinoic acid in β cyclodextrin, Int. J. Pharm., 54, 173-179, (1989).
10. H. Arima, H. Adachi, T. Irie, K. Uekama, and J. Pitha, Enhancement of the anti-inflammatory effect of Ethyl 4- biphenylyl acetate in ointment by β-cyclodextrin derivatives: increased absorption and localized activation of the prodrug in rats, Pharm. Res., 7, 1152-1156 (1990).
11. L. Santucci, S. Fiorucci, L. Patoia, F. Farroni, A. Sicilia, S. Chiacchia, L. Bufalino, and A. Morelli, Gastric tolerance of piroxicam-β cyclodextrin compared with placebo and with other NSAIDS, an endoscopic and functional study by evaluation of transmucosal potential difference, Drug Invest., 2(suppl. 4), 56-60 (1990).
12. D. Amdidouche, R. Montassier, D. Duchène, and M-C Poelman, Evaluation by laser Doppler velocimetry of the attenuation of tretinoin induced skin irritation by β cyclodextrin complexation, Int. J. Pharm., 111, 111- 116, (1994).
13. T. Backensfeld, B. W. Müller, M. Wiese, and J. K. Seydel, Effect of cyclodextrin derivatives on indomethacin stability in aqueous solution, Pharm Res., 7, 484- 490 (1990).
14. L. Gracza and P. Ruff, Einfache Methode zur Trennung und quantiativen Bestimmung von Kava-Laktonen durch Hochleistungs-Flüssigkeits-chromatographie, J. Chromatogr., 193, 486-490 (1980).